AtriCure, Inc., a leading innovator in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2000, the company has made significant strides in the development of advanced technologies for the treatment of atrial fibrillation and other cardiac conditions. AtriCure's core offerings include a range of surgical and ablation devices that are distinguished by their unique energy delivery systems, designed to improve patient outcomes and enhance procedural efficiency. With a strong market position, AtriCure has achieved notable milestones, including FDA approvals and recognition for its commitment to advancing cardiac care. The company continues to be at the forefront of innovation, dedicated to transforming the landscape of heart surgery.
How does AtriCure, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AtriCure, Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AtriCure, Inc., headquartered in the US, currently does not have available data on its carbon emissions, as indicated by the absence of reported figures. Consequently, there are no specific emissions totals or breakdowns by Scope 1, 2, or 3 emissions. In terms of climate commitments, AtriCure has not outlined any reduction targets or initiatives in the provided data. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, AtriCure's future commitments and actions will be crucial in aligning with global climate goals and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AtriCure, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

